{"altmetric_id":4070724,"counts":{"readers":{"mendeley":10,"citeulike":0,"connotea":0},"total":{"posts_count":1},"twitter":{"unique_users_count":1,"unique_users":["scottsdalem"],"posts_count":1}},"selected_quotes":["$HRTX Palanosetron in phase-3 trial with more subjects (1400+) already superior to SUSTOL. Read here."],"citation":{"altmetric_jid":"4f6fa63b3cf058f610008df2","authors":["Celio L","Agustoni F","Ricchini F","Dotti K","Niger M","Braud FD"],"doi":"10.2217\/fon.13.153","first_seen_on":"2015-05-29T11:09:34+00:00","issns":["1479-6694"],"issue":"10","journal":"Future Oncology","last_mentioned_on":1432897746,"links":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24106896"],"pmid":"24106896","pubdate":"2013-10-14T23:00:00+00:00","publisher_subjects":[{"name":"Oncology And Carcinogenesis","scheme":"era"}],"scopus_subjects":["Health Sciences","Medicine","Life Sciences","Biochemistry, Genetics and Molecular Biology"],"subjects":["neoplasms"],"title":"Palonosetron plus dexamethasone in highly emetogenic chemotherapy: pooled data from two Phase III trials.","type":"article","volume":"9","mendeley_url":"http:\/\/www.mendeley.com\/research\/palonosetron-plus-dexamethasone-highly-emetogenic-chemotherapy-pooled-data-two-phase-iii-trials-2"},"altmetric_score":{"score":1,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":1},"context_for_score":{"all":{"total_number_of_other_articles":5163199,"mean":6.0993027755301,"rank":2728044,"this_scored_higher_than_pct":34,"this_scored_higher_than":1762778,"rank_type":"exact","sample_size":5163199,"percentile":34},"similar_age_3m":{"total_number_of_other_articles":172966,"mean":8.8390236521841,"rank":97889,"this_scored_higher_than_pct":33,"this_scored_higher_than":58042,"rank_type":"exact","sample_size":172966,"percentile":33},"this_journal":{"total_number_of_other_articles":553,"mean":2.2070434782609,"rank":211,"this_scored_higher_than_pct":49,"this_scored_higher_than":274,"rank_type":"exact","sample_size":553,"percentile":49},"similar_age_this_journal_3m":{"total_number_of_other_articles":20,"mean":0.82105263157895,"rank":7,"this_scored_higher_than_pct":60,"this_scored_higher_than":12,"rank_type":"exact","sample_size":20,"percentile":60}}},"demographics":{"poster_types":{"member_of_the_public":1},"users":{"twitter":{"cohorts":{"Members of the public":1}},"mendeley":{"by_status":{"Professor > Associate Professor":1,"Librarian":1,"Researcher":2,"Student  > Postgraduate":3,"Other":1,"Student  > Bachelor":2},"by_discipline":{"Medicine and Dentistry":8,"Agricultural and Biological Sciences":1,"Pharmacology, Toxicology and Pharmaceutical Science":1}}}},"posts":{"twitter":[{"url":"https:\/\/twitter.com\/scottsdalem\/status\/604243061569376257","license":"datasift","citation_ids":[4070724],"posted_on":"2015-05-29T11:09:06+00:00","author":{"name":"Hope&Luck","image":"http:\/\/abs.twimg.com\/sticky\/default_profile_images\/default_profile_2_normal.png","id_on_source":"scottsdalem","tweeter_id":"2821217758","followers":24},"tweet_id":"604243061569376257"}]}}